Long-term Reduction in Brain MRI Disease Activity and Atrophy after 5 years of Ocrelizumab Treatment in Patients with Relapsing Multiple Sclerosis
Titel:
Long-term Reduction in Brain MRI Disease Activity and Atrophy after 5 years of Ocrelizumab Treatment in Patients with Relapsing Multiple Sclerosis
Auteur:
Arnold, D.L. Kappos, L. Hauser, S.L. Montalban, X. Traboulsee, A. Wolinsky, J.S. Manfrini, M. Levesque, V. Villoslada, P. Belachew, S. Model, F. Hubeaux, S. Bar-Or, A.